FindTrial
Sign In

Anatomic enucleation of the prostate for the treatment of benign prostatic hyperplasia

Multi center randomized controlled study for the anatomic enucleation of the prostate for the treatment of benign prostatic hyperplasia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009740
Enrollment
Unknown
Registered
2016-11-05
Start date
2016-12-05
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

HoLEP:HoLEP
TURP:TURP

Sponsors

Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. More than 2 times of urine retention; Residual urine>100ml; 2. Poor effect of the use of 5ARI and a-receptor blocker and IPSS>15; 3. Urinary tract infection and bladder stones or the bladder disfunction caused by the BPH; 4. Archoptoma,hydronephrosis,inguinal hernia,haemorrhoids,bladder diverticula or urinary infection combined with the BPH.

Exclusion criteria

Exclusion criteria: 1. Qmax>20ml/s; 2. Neurogenic bladder; 3. Injuries in the low urinary tract and the prostate; 4. Bladder cancer or the prostate cancer during our treatment or the follow up; 5. Structures in the urinary tract and bladder neck.

Design outcomes

Primary

MeasureTime frame
perioperative data;follow-up data;—

Secondary

MeasureTime frame
Patients’ characteristics;—

Countries

China

Contacts

Public ContactWang Zhong

Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine

zhongwang2000@sina.com+86 13301980998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026